Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen

NCT07145827 is registered in ClinicalTrials.gov with Uruk University as lead sponsor.

NCT NCT07145827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen
Lead sponsor
Uruk University
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2024
Completion date
July 1, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, endometrial hyperplasia and endometrial cancers